Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C

Bart Veldt, HJJ van der Vliet, BME von Blomberg, H van Vlierberghe, G Gerken, N Nishi, K Hayashi, RJ Scheper, Rob de Knegt, AJM (Fons) van den Eertwegh, HLA Janssen, CMJ van Nieuwkerk

Research output: Contribution to journalArticleAcademicpeer-review

64 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)356-365
Number of pages10
JournalJournal of Hepatology
Volume47
Issue number3
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-04-20-02-A

Cite this